Manager TitleAgeSince
Chief Operating Officer 67 01/01/2006
Chief Executive Officer 73 -
Chief Executive Officer 50 29/12/2023
Director TitleAgeSince
Chairman 73 16/12/2024
Director/Board Member 67 01/01/2006
Chairman - -
Change 5-day change 1-year change 3-year change Capi.($)
-12.13%-36.36% - - 1.4M
+4.16%+4.16%+49.37%+94.17% 74.69B
-1.44%-2.69%+21.35%+76.45% 58.81B
0.00%+0.38%+6.89%+34.59% 48.45B
-3.76%-2.25%+329.09%+698.20% 42.84B
-2.30%-3.35%+26.81%+30.88% 42.79B
+0.31%-0.68%+5.30%+108.64% 41.25B
-0.11%+1.96%+9.19%+52.66% 31.13B
-2.07%+1.16%+35.00%+26.28% 30.28B
-1.96%-2.88%-8.97%-13.92% 24.05B
Average -1.91%-0.25%+52.67%+123.11% 43.81B
Weighted average by Cap. -0.31%-0.54%+55.47%+129.40%
Logo 2cureX AB
2cureX AB is a Sweden-based company engaged in the biotechnology sector. The Company focuses on the research and development of diagnostic substances to select treatment for cancer patients. The Company's product candidate, IndiTreat - CRC, aims at optimizing medical treatment for the colorectal cancer patients. Through IndiTreat - CRC, healthcare professionals collect a tumor sample from patients to create a number of three-dimensional micro tumors in order to test available chemotherapies and experimental treatments. The Company's product pipeline includes also IndiTreat - OVA, targeting ovarian cancer treatment, and IndiTreat - KDN, focusing on kidney cancer treatment. It operates through 2cureX A/S.
Employees
14
  1. Stock Market
  2. Stocks
  3. 2CUREX Stock